Hepatoblastoma is a rare malignant tumor of the liver that occurs in childr
en at an average age of 2 to 3 years. Epidemiologic studies have shown an i
ncreased frequency of this tumor type in families affected by adenomatous p
olyposis coli. In addition to the epidemiologic data, molecular genetic stu
dies suggest that inactivation of the APC tumor suppressor may be involved
in hepatoblastoma tumorigenesis, A major function of APC is the downregulat
ion of beta-catenin, a transcription-activating protein with oncogenic pote
ntial. In an ongoing immunohistochemical study of beta-catenin expression i
n sporadic cases of tumor types that are associated with adenomatous polypo
sis coli, we observed increased beta-catenin levels in the cytoplasm and in
the nuclei of three investigated hepatoblastomas. Sequencing of exon 3 of
the beta-catenin gene (CTNNB1) revealed an activating mutation in one of th
e tumor samples. Our data indicate for the first time that beta-catenin acc
umulation may play a role in the development of hepatoblastoma and that act
ivating mutations of the beta-catenin gene may substitute biallelic APC ina
ctivation in this tumor type. Genes Chromosomes Cancer 25:399-402, 1999. (C
) 1999 Wiley-Liss, Inc.